Consolidated Statement Of Changes In Equity

KISSEI PHARMACEUTICAL CO.,LTD. - Filing #7252445

Concept As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
Consolidated statement of changes in equity
Statement of changes in equity
Net assets
830,000,000 JPY
-14,520,000,000 JPY
24,247,000,000 JPY
38,577,000,000 JPY
24,247,000,000 JPY
38,752,000,000 JPY
4,701,000,000 JPY
1,122,000,000 JPY
158,451,000,000 JPY
68,100,000,000 JPY
24,356,000,000 JPY
165,550,000,000 JPY
43,453,000,000 JPY
-14,520,000,000 JPY
24,356,000,000 JPY
24,226,000,000 JPY
JPY
124,368,000,000 JPY
940,000,000 JPY
131,488,000,000 JPY
54,497,000,000 JPY
210,126,000,000 JPY
197,028,000,000 JPY
38,577,000,000 JPY
830,000,000 JPY
1,107,000,000 JPY
24,356,000,000 JPY
4,562,000,000 JPY
156,007,000,000 JPY
24,247,000,000 JPY
-13,209,000,000 JPY
120,613,000,000 JPY
52,593,000,000 JPY
52,593,000,000 JPY
52,782,000,000 JPY
24,226,000,000 JPY
940,000,000 JPY
127,310,000,000 JPY
50,741,000,000 JPY
24,247,000,000 JPY
68,100,000,000 JPY
-13,209,000,000 JPY
JPY
24,356,000,000 JPY
221,136,000,000 JPY
162,683,000,000 JPY
57,344,000,000 JPY
208,601,000,000 JPY
830,000,000 JPY
32,653,000,000 JPY
30,256,000,000 JPY
119,732,000,000 JPY
940,000,000 JPY
24,356,000,000 JPY
24,356,000,000 JPY
49,860,000,000 JPY
0 JPY
30,256,000,000 JPY
161,246,000,000 JPY
185,679,000,000 JPY
30,393,000,000 JPY
24,226,000,000 JPY
24,247,000,000 JPY
-12,912,000,000 JPY
-12,912,000,000 JPY
68,100,000,000 JPY
2,259,000,000 JPY
914,000,000 JPY
24,247,000,000 JPY
194,814,000,000 JPY
155,423,000,000 JPY
125,576,000,000 JPY
Changes during period
Dividends of surplus
-3,801,000,000 JPY
-3,801,000,000 JPY
-3,801,000,000 JPY
-3,801,000,000 JPY
-3,801,000,000 JPY
-3,801,000,000 JPY
-3,801,000,000 JPY
-3,722,000,000 JPY
-3,722,000,000 JPY
-3,722,000,000 JPY
-3,722,000,000 JPY
-3,722,000,000 JPY
-3,722,000,000 JPY
-3,722,000,000 JPY
Profit (loss) attributable to owners of parent
11,961,000,000 JPY
11,961,000,000 JPY
11,961,000,000 JPY
11,160,000,000 JPY
11,160,000,000 JPY
11,160,000,000 JPY
Net changes in items other than shareholders' equity
-14,029,000,000 JPY
-13,890,000,000 JPY
-14,016,000,000 JPY
14,000,000 JPY
-14,016,000,000 JPY
139,000,000 JPY
-13,876,000,000 JPY
-14,016,000,000 JPY
192,000,000 JPY
2,302,000,000 JPY
22,336,000,000 JPY
22,336,000,000 JPY
24,690,000,000 JPY
22,336,000,000 JPY
22,388,000,000 JPY
24,883,000,000 JPY
Total changes during period
JPY
JPY
-14,029,000,000 JPY
JPY
-13,890,000,000 JPY
-14,016,000,000 JPY
-1,311,000,000 JPY
-1,311,000,000 JPY
JPY
JPY
14,000,000 JPY
JPY
3,755,000,000 JPY
2,443,000,000 JPY
-11,572,000,000 JPY
2,866,000,000 JPY
139,000,000 JPY
JPY
JPY
-11,009,000,000 JPY
4,178,000,000 JPY
3,755,000,000 JPY
-14,016,000,000 JPY
JPY
JPY
192,000,000 JPY
881,000,000 JPY
1,437,000,000 JPY
JPY
JPY
JPY
2,302,000,000 JPY
JPY
584,000,000 JPY
JPY
22,921,000,000 JPY
0 JPY
-296,000,000 JPY
22,336,000,000 JPY
24,690,000,000 JPY
22,336,000,000 JPY
881,000,000 JPY
22,388,000,000 JPY
1,734,000,000 JPY
0 JPY
26,321,000,000 JPY
-296,000,000 JPY
0 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.